Sarah Worth

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

University of Alabama at Birmingham(Current)

Sarah Worth is an author at University of Alabama at Birmingham specializing in chemotherapy in hematologic malignancies, chemotherapy, and hematologic malignancy pharmacotherapy.

ORCID

Publications per year

2022–2022

Publications

Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia

Sankalp Arora, Carl Zainaldin, Srilakshmi Bathini et al. · Leukemia Research · 2022 · 17 citations

Medicine, Hematology, Pharmacotherapy +14

Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents

Carl Zainaldin, Sankalp Arora, Srilakshmi Bathini et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2022 · 11 citations

Medicine, Hematology, Oncology +14

1–2 of 2